Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry
I Witzel, E Laakmann, R Weide, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
M Ignatiadis, S Litière, F Rothe, et al.
ESMO Open
|
June 2, 2022
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
E Laakmann, I Witzel, T Neunhöffer, et al.
ESMO Open
|
April 19, 2023
Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry
K Riecke, V Müller, T Neunhöffer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2013
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
C Denkert, S Loibl, B M Müller, et al.
Oncogene
|
January 10, 2017
Analysis of DNA methylation in single circulating tumor cells
C F Pixberg, K Raba, F Müller, et al.
ESMO Open
|
March 22, 2025
Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay
W Janni, B Rack, T W P Friedl, et al.
ESMO Open
|
November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
V Müller, M Banys-Paluchowski, T W P Friedl, et al.
Gynecologic Oncology
|
December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)
F T Roncolato, R L O'Connell, F Joly, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry
I Witzel, E Laakmann, R Weide, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
M Ignatiadis, S Litière, F Rothe, et al.
ESMO Open
|
June 2, 2022
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
E Laakmann, I Witzel, T Neunhöffer, et al.
ESMO Open
|
April 19, 2023
Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry
K Riecke, V Müller, T Neunhöffer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2013
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
C Denkert, S Loibl, B M Müller, et al.
Oncogene
|
January 10, 2017
Analysis of DNA methylation in single circulating tumor cells
C F Pixberg, K Raba, F Müller, et al.
ESMO Open
|
March 22, 2025
Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay
W Janni, B Rack, T W P Friedl, et al.
ESMO Open
|
November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
V Müller, M Banys-Paluchowski, T W P Friedl, et al.
Gynecologic Oncology
|
December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)
F T Roncolato, R L O'Connell, F Joly, et al.
Page
of 10